报告血脂康治疗脑梗塞伴高脂血症临床观察30例,总有效率:80％,总显效率:53％;观察高脂血症疗效:总有效率:87％,总显效率:27％。治疗前后P<0.001,有极显著疗效,证明血脂康不但有明显降血脂作用,而且还可促进脑梗塞功能恢复,并减少病残程度,长期服用无明显副作用。 Report Xuezhikang treatment of cerebral infarction with hyperlipidemia in the clinical observation of 30 cases, the total effective rate: 80%, total effective rate: 53%; observed hyperlipidemia efficacy: total effective rate: 87%, total effective rate: 27% . P <0.001 before and after treatment, there is a very significant effect, not only shows Xuezhikang not only significantly reduce the role of lipid-lowering, but also to promote functional recovery of cerebral infarction and reduce the degree of sickness, long-term use without obvious side effects.